ScholarIQanswers from OpenAlex
Shandong Tumor Hospital
InstitutionResearch output, impact & collaborations
Shandong Tumor Hospital is a institution indexed in ScholarIQ from OpenAlex.
What is known about Shandong Tumor Hospital?
ScholarIQrecord summary
Shandong Tumor Hospital is a research organisation in Jinan, CN. OpenAlex records 9,222 works and 402,879 citations for it. 2,426 researchers list it as their most recent affiliation.
How many works does Shandong Tumor Hospital have?
ScholarIQindexed works
Shandong Tumor Hospital has 9,222 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Shandong Tumor Hospital have?
ScholarIQcitation count
Shandong Tumor Hospital has 402,879 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Shandong Tumor Hospital?
ScholarIQresearcher count
Shandong Tumor Hospital has 2,426 researchers in the ScholarIQ index.
What is the average h-index at Shandong Tumor Hospital?
ScholarIQavg h-index
Shandong Tumor Hospital has an average h-index of 84 in OpenAlex.
What is the ROR of Shandong Tumor Hospital?
ScholarIQror
The ROR for Shandong Tumor Hospital is on the source record.
What is the OpenAlex record for Shandong Tumor Hospital?
ScholarIQopenalex
The OpenAlex for Shandong Tumor Hospital is on the source record.
Who are the most-cited researchers behind Shandong Tumor Hospital?
ScholarIQtop researchers by citations
What are the most-cited papers on Shandong Tumor Hospital?
ScholarIQmost cited works
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, Amirhossein Zabolian, Hossein Saleki, Mohamad Javad Naghdi, Sina Sabet, Mohammad Amin Khoshbakht, Mehrdad Hashemi, Kiavash Hushmandi, Gautam Sethi, Ali Zarrabi, Alan Prem Kumar, Shing Cheng Tan, Marios Papadakis, Αθανάσιος Αλεξίου, Md Asiful Islam, Ebrahim Mostafavi, Milad Ashrafizadeh
RETRACTED: AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation
Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, Amirhossein Zabolian, Shima Mohammadi, Farima Fakhri, Mehrdad Hashemi, Kiavash Hushmandi, Milad Ashrafizadeh, Ali Zarrabi, Yavuz Nuri Ertaş, Sepideh Mirzaei, Saeed Samarghandian
The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway
Tahereh Farkhondeh, Sílvia Llorens, Ali Mohammad Pourbagher‐Shahri, Milad Ashrafizadeh, Saeed Samarghandian
Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury
Milad Ashrafizadeh, Zahra Ahmadi, Reza Mohammadinejad, Tahereh Farkhondeh, Saeed Samarghandian
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, Ashkan Bigham, Esmaeel Sharifi, Navid Rabiee, Ana Cláudia Paiva‐Santos, Alan Prem Kumar, Shing Cheng Tan, Kiavash Hushmandi, Jun Ren, Ehsan Nazarzadeh Zare, Pooyan Makvandi
How much of the research on Shandong Tumor Hospital is open access?
ScholarIQopen access share
83%OPEN ACCESS